During the recent session, IN8bio Inc (NASDAQ:INAB)’s traded shares were 0.4 million, with the beta value of the company hitting 0.01. The 52-week high for the INAB share is $1.74, that puts it down -544.44 from that peak though still a striking 18.52% gain since the share price plummeted to a 52-week low of $0.22. The company’s market capitalization is $19.42M, and the average trade volume was 5.46 million shares over the past three months.
IN8bio Inc (INAB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. INAB has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.08.
IN8bio Inc (NASDAQ:INAB) trade information
IN8bio Inc (INAB) registered a -0.04% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.04% in intraday trading to $0.27, hitting a weekly high. The stock’s 5-day price performance is 5.72%, and it has moved by 5.56% in 30 days. Based on these gigs, the overall price performance for the year is -77.86%.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -50.62%. While earnings are projected to return 43.67% in 2025, the next five years will return 32.08% per annum.
INAB Dividends
IN8bio Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
IN8bio Inc (NASDAQ:INAB)’s Major holders
The next largest institutional holding, with 1.42 million shares, is of VANGUARD GROUP INC’s that is approximately 3.2892% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.21 million.
Also, the Mutual Funds coming in first place with the largest holdings of IN8bio Inc (INAB) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 952.49 shares. This amounts to just over 1.31 percent of the company’s overall shares, with a $0.26 million market value. The same data shows that the other fund manager holds slightly less at 471.41, or about 0.65% of the stock, which is worth about $0.13 million.
